\n\n

Common antidepressant may ease long COVID’s crushing fatigue

A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.

Related Posts

Common antidepressant may ease long COVID’s crushing fatigue

A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of…

Popular sugar substitutes linked to faster brain aging

Several popular sugar substitutes may not be as harmless as they seem. Adults who consumed the most artificial sweeteners showed substantially faster declines in memory and thinking, especially if they…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Tom Homan says ICE is breaking records, still holds goal of ‘mass deportations’

Tom Homan says ICE is breaking records, still holds goal of ‘mass deportations’

Divide grows between AI employees and executives over policy battles

Divide grows between AI employees and executives over policy battles

Jon Ossoff, amid presidential chatter, hits Trump over elections

Jon Ossoff, amid presidential chatter, hits Trump over elections

Hegseth’s testosterone mandate carries risks, raises questions

Hegseth’s testosterone mandate carries risks, raises questions

Ferry carrying 116 passengers sinks off Guyana coast, authorities say

Ferry carrying 116 passengers sinks off Guyana coast, authorities say

From settlements to blocked recovery: Israeli strategy taking shape in Gaza

From settlements to blocked recovery: Israeli strategy taking shape in Gaza